221 related articles for article (PubMed ID: 20395540)
1. VIP/PACAP receptor mediation of cutaneous active vasodilation during heat stress in humans.
Kellogg DL; Zhao JL; Wu Y; Johnson JM
J Appl Physiol (1985); 2010 Jul; 109(1):95-100. PubMed ID: 20395540
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide and receptors for VIP and PACAP in cutaneous active vasodilation during heat stress in humans.
Kellogg DL; Zhao JL; Wu Y; Johnson JM
J Appl Physiol (1985); 2012 Nov; 113(10):1512-8. PubMed ID: 22961270
[TBL] [Abstract][Full Text] [Related]
3. Stimulatory effect of pituitary adenylate cyclase-activating polypeptide 6-38, M65 and vasoactive intestinal polypeptide 6-28 on trigeminal sensory neurons.
Sághy É; Payrits M; Helyes Z; Reglődi D; Bánki E; Tóth G; Couvineau A; Szőke É
Neuroscience; 2015 Nov; 308():144-56. PubMed ID: 26321242
[TBL] [Abstract][Full Text] [Related]
4. Roles of nitric oxide synthase isoforms in cutaneous vasodilation induced by local warming of the skin and whole body heat stress in humans.
Kellogg DL; Zhao JL; Wu Y
J Appl Physiol (1985); 2009 Nov; 107(5):1438-44. PubMed ID: 19745188
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of soluble guanylyl cyclase attenuates cutaneous vasodilation during whole body heat stress and local warming in humans.
Kellogg DL; Zhao JL; Wu Y; Johnson JM
J Appl Physiol (1985); 2011 May; 110(5):1406-13. PubMed ID: 21292837
[TBL] [Abstract][Full Text] [Related]
6. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
[TBL] [Abstract][Full Text] [Related]
7. PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: involvement of PAC1/VPAC2 receptor-mediated activation of PI3K/Akt signaling pathways.
Castorina A; Scuderi S; D'Amico AG; Drago F; D'Agata V
Exp Cell Res; 2014 Mar; 322(1):108-21. PubMed ID: 24246222
[TBL] [Abstract][Full Text] [Related]
8. Backup Mechanisms Maintain PACAP/VIP-Induced Arterial Relaxations in Pituitary Adenylate Cyclase-Activating Polypeptide-Deficient Mice.
Ivic I; Fulop BD; Juhasz T; Reglodi D; Toth G; Hashimoto H; Tamas A; Koller A
J Vasc Res; 2017; 54(3):180-192. PubMed ID: 28490016
[TBL] [Abstract][Full Text] [Related]
9. No direct role for A1/A2 adenosine receptor activation to reflex cutaneous vasodilatation during whole-body heat stress in humans.
Fieger SM; Wong BJ
Acta Physiol (Oxf); 2012 Jul; 205(3):403-10. PubMed ID: 22356216
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure-induced vasodilatation in rodents.
Fizanne L; Sigaudo-Roussel D; Saumet JL; Fromy B
J Physiol; 2004 Jan; 554(Pt 2):519-28. PubMed ID: 14578481
[TBL] [Abstract][Full Text] [Related]
11. Evidence for a role for vasoactive intestinal peptide in active vasodilatation in the cutaneous vasculature of humans.
Bennett LA; Johnson JM; Stephens DP; Saad AR; Kellogg DL
J Physiol; 2003 Oct; 552(Pt 1):223-32. PubMed ID: 12847205
[TBL] [Abstract][Full Text] [Related]
12. Pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide inhibit dendritic growth in cultured sympathetic neurons.
Drahushuk K; Connell TD; Higgins D
J Neurosci; 2002 Aug; 22(15):6560-9. PubMed ID: 12151535
[TBL] [Abstract][Full Text] [Related]
13. Endothelial nitric oxide synthase control mechanisms in the cutaneous vasculature of humans in vivo.
Kellogg DL; Zhao JL; Wu Y
Am J Physiol Heart Circ Physiol; 2008 Jul; 295(1):H123-9. PubMed ID: 18469149
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
[TBL] [Abstract][Full Text] [Related]
15. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
Akesson L; Ahrén B; Edgren G; Degerman E
Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
[TBL] [Abstract][Full Text] [Related]
16. PAC1 receptors mediate pituitary adenylate cyclase-activating polypeptide- and progesterone-facilitated receptivity in female rats.
Apostolakis EM; Riherd DN; O'Malley BW
Mol Endocrinol; 2005 Nov; 19(11):2798-811. PubMed ID: 15976009
[TBL] [Abstract][Full Text] [Related]
17. Pituitary adenylate cyclase-activating polypeptide (PACAP) potently dilates middle meningeal arteries: implications for migraine.
Syed AU; Koide M; Braas KM; May V; Wellman GC
J Mol Neurosci; 2012 Nov; 48(3):574-83. PubMed ID: 22766684
[TBL] [Abstract][Full Text] [Related]
18. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary.
Barberi M; Muciaccia B; Morelli MB; Stefanini M; Cecconi S; Canipari R
Reproduction; 2007 Aug; 134(2):281-92. PubMed ID: 17660238
[TBL] [Abstract][Full Text] [Related]
19. Adenosine receptor inhibition with theophylline attenuates the skin blood flow response to local heating in humans.
Fieger SM; Wong BJ
Exp Physiol; 2010 Sep; 95(9):946-54. PubMed ID: 20562295
[TBL] [Abstract][Full Text] [Related]
20. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
